Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations

Published:2024-08-02 Issue: Volume: Page:
ISSN:2688-1527
Container-title:JCO Oncology Practice
language:en
Short-container-title:JCO Oncol Pract

Author:

Gupta Arjun¹^ORCID,Tregear Michelle²,Pace Makala B.³^ORCID,Vogel Rachel I.⁴⁵^ORCID

Affiliation:

1. Divsion of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, MN

2. National Breast Cancer Coalition, Washington, DC

3. Pharmacy Services, Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT

4. Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, Minneapolis, MN

5. Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Abstract

Time and other considerations when evaluating a switch to newer drug formulations (eg, subQ vs IV).

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/OP-24-00501

Reference12 articles.

1. Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access

2. Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review

3. Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers

4. Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice

5. The Time Toxicity of Cancer Treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3